Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn’s Disease: Reflects Inflammation and Drug Effects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn’s Disease: Reflects Inflammation and Drug Effects
Authors
Keywords
Biopsy, Cytokines, Immunohistochemistry techniques, Inflammation, Colon, Endoscopy, Drug screening, Inflammatory bowel disease
Journal
PLoS One
Volume 11, Issue 5, Pages e0155335
Publisher
Public Library of Science (PLoS)
Online
2016-05-13
DOI
10.1371/journal.pone.0155335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
- (2015) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
- (2015) Itay Raphael et al. CYTOKINE
- The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals
- (2015) Peter J.K. van Meer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ex vivo paracrine properties of cardiac tissue: Effects of chronic heart failure
- (2015) Robert J. Boucek et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
- (2014) Mahmoud H Mosli et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diagnosis and classification of Crohn's disease
- (2014) Martin W. Laass et al. AUTOIMMUNITY REVIEWS
- Cytokines and cytokine receptors as immunotherapeutics: humble beginnings and exciting futures
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- An update on medical management on Crohn’s disease
- (2014) Andrea Affronti et al. EXPERT OPINION ON PHARMACOTHERAPY
- A CD3-Specific Antibody Reduces Cytokine Production and Alters Phosphoprotein Profiles in Intestinal Tissues From Patients With Inflammatory Bowel Disease
- (2014) Anna Vossenkämper et al. GASTROENTEROLOGY
- Who Should Receive Biologic Therapy for IBD?
- (2014) Jennifer Jones et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
- (2014) Raquel Franco Leal et al. GUT
- Distinctive Colonic Mucosal Cytokine Signature in New-Onset, Untreated Pediatric Crohn Disease
- (2014) Francisco A. Sylvester et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Use of animal models in elucidating disease pathogenesis in IBD
- (2014) Puja Vora Khanna et al. Seminars in Immunopathology
- Biologic therapies in inflammatory bowel disease
- (2014) Lawrence B. Cohen et al. Translational Research
- Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model
- (2014) Fransisca Leonard ALTEX-Alternatives to Animal Experimentation
- Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease treated with anti-TNF antibodies
- (2014) Lior H. Katz et al. Clinics and Research in Hepatology and Gastroenterology
- C-reactive protein in Crohn’s disease: how informative is it?
- (2014) Fernando Magro et al. Expert Review of Gastroenterology & Hepatology
- Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents
- (2013) Roslyn Kemp et al. BIODRUGS
- Anti-IL-12/23 in Crohn's Disease: Bench and Bedside
- (2013) Lukas Niederreiter et al. CURRENT DRUG TARGETS
- Inflammatory bowel disease epidemiology
- (2013) Johan Burisch et al. CURRENT OPINION IN GASTROENTEROLOGY
- Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis
- (2013) Bart Lemmens et al. INFLAMMATORY BOWEL DISEASES
- New targets for mucosal healing and therapy in inflammatory bowel diseases
- (2013) M F Neurath Mucosal Immunology
- Insight into Crohn’s disease pathomorphology
- (2012) Jonas Mudter et al. ABDOMINAL IMAGING
- Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model
- (2012) Katerina Tsilingiri et al. GUT
- Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system
- (2012) Darab Ghadimi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
- (2011) Der-Yuan Chen et al. ARTHRITIS RESEARCH & THERAPY
- Proinflammatory cytokines underlying the inflammation of Crohnʼs disease
- (2010) Warren Strober et al. CURRENT OPINION IN GASTROENTEROLOGY
- A Three-Dimensional Coculture of Enterocytes, Monocytes and Dendritic Cells To Model Inflamed Intestinal Mucosa in Vitro
- (2010) Fransisca Leonard et al. MOLECULAR PHARMACEUTICS
- The Genetics of Crohn's Disease
- (2009) Johan Van Limbergen et al. Annual Review of Genomics and Human Genetics
- Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
- (2009) L. Rovedatti et al. GUT
- Translating Inflammatory Bowel Disease Research into Clinical Medicine
- (2009) Markus F. Neurath et al. IMMUNITY
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells
- (2008) Takeshi Tanoue et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation
- (2008) Yinghua Xu et al. CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More